PNTC Presents Findings at Two Major Conferences

October 14, 2026 | Spotlight
PNTC Presents Posters

We’re proud to celebrate our team’s contributions to advancing precision therapeutics for neurological disorders! Members of our team recently shared their findings at two major conferences:

🔬 Alexander Diefes presented “An Antisense Oligonucleotide Therapeutic Platform Approach for Haploinsufficient Monogenic Neurodevelopmental Disorders” at both the N=1 Collaborative Annual Meeting and the Oligonucleotide Therapeutics Society Annual Meeting.

🔬 Aastha Ghandi presented “Allele-Specific ASOs as a Precision Therapeutic Strategy for AFG3L2-Related Diseases” at the Oligonucleotide Therapeutics Society Annual Meeting.

Both projects explore innovative antisense oligonucleotide (ASO) approaches to developing targeted therapeutic strategies for genetic neurological disorders.

Congratulations to Alex and Aastha for sharing their work and contributing to progress in this important area of research!